Quick Answer
Pelthos Therapeutics Inc. reported Cash And Cash Equivalents At Carrying Value of $17.97 million for the year ending 2025.
- Pelthos Therapeutics Inc. showed an increase of +3,403.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Pelthos Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $17.97 million | Fiscal year 2024: $513.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: